Home » Topics » BioWorld

BioWorld
RSS

TUESDAY'S STOCKS

May 20, 1992

PROCYTE RAISES $6.9M IN REDUCED OFFERING

May 20, 1992

SECOND PHASE III TRIAL FOR RIBI'S MELACINE

May 20, 1992

NOVA BEGINS TRIALS OF SEPSIS TREATMENT

May 20, 1992

GLYCOMED READIES FIRST PRODUCT FOR CLINIC

May 20, 1992

CORTECH SHOCK TREATMENT TO CLINIC

May 20, 1992

APPLIED MICRO FINDS AN ANGEL

May 20, 1992

OSTEOTECH COMPLETES ACQUISITION

May 19, 1992

REPLIGEN-LILLY DEAL WORTH MORE THAN $14M

May 19, 1992

XYTRONYX RAISES $3.2 MILLION

May 19, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
DOJ arrests shed light on Medicare skin substitute controversy
BioWorld MedTech
Much has been made of the recent skyrocketing of Medicare spending on skin substitutes, but a new enforcement action by the U.S. Department of Justice might help...